設備免疫組織化學市場:趨勢、機會與競爭分析 [2023-2028]
市場調查報告書
商品編碼
1342061

設備免疫組織化學市場:趨勢、機會與競爭分析 [2023-2028]

Equipment Immunohistochemistry Market: Trends, Opportunities and Competitive Analysis [2023-2028]

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

設備免疫組織化學市場趨勢與預測

預計到2028年,全球免疫組織化學設備市場將達到 6.2 億美元,2023年至2028年年複合成長率為 5.1%。該市場的主要促進因素是慢性病和感染疾病的增加,以及對用於檢查組織樣本中蛋白質和大分子等成分的顯微鏡技術的需求不斷增加。免疫組織化學設備市場的未來看起來充滿希望,在醫院、診斷實驗室和學術機構中都有機會。

免疫組織化學設備市場洞察

  • Lucintel 預測,由於免疫組織化學在診斷固態腫瘤和細胞學標本中的大量使用,診斷領域預計將在預測期內實現最高成長。
  • 由於大量使用免疫組織化學來確定細胞內特定生物學成分的位置和分佈,預計診斷實驗室仍將是最大的區隔。
  • 由於診斷設施和實驗室對免疫組織化學設備的需求不斷增加、支持性償付政策的存在以及該地區老年人口的不斷成長,預計北美仍將是最大的地區。

本報告回答了 11 個關鍵問題:

  • Q.1.細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.哪些地區未來會出現更快的成長?為什麼?
  • Q.4.影響市場動態的主要要素有哪些?市場的主要挑戰和業務風險是什麼?
  • Q.5.這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?此外,主要企業採取什麼樣的策略配合措施?
  • Q10.該市場的競爭產品有哪些?因材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q11.過去年度發生了哪些併購事件,對產業產生了哪些影響?

目錄

第1章 執行摘要

第2章 全球設備免疫組織化市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

  • 宏觀經濟趨勢(2017-2022)與預測(2023-2028)
  • 全球設備免疫組織化學市場趨勢(2017-2022)與預測(2023-2028)
  • 全球設備免疫組織化學市場(依應用)
    • 診斷
    • 癌症
    • 傳染性
    • 腎臟疾病
    • 自體免疫疾病
    • 神經系統疾病
    • 調查
    • 法醫學
    • 其他
  • 依最終用途的全球免疫組織化學設備市場
    • 醫院
    • 診斷實驗室
    • 學術機構
    • 其他

第4章 2017-2028年分地區市場趨勢及預測分析

  • 全球設備免疫組化市場(依地區)
  • 北美設備免疫組織化學市場
  • 歐洲免疫組化設備市場
  • 亞太設備免疫組織化學市場
  • 其他區域免疫組織設備市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球設備免疫組織化學市場成長機會(依應用)
    • 全球設備免疫組織化學市場成長機會(依最終用途)
    • 依地區分類的全球設備免疫組織化學市場成長機會
  • 全球設備免疫組織化學市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球設備免疫組織化學市場產能擴張
    • 全球設備免疫組織化學市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories
簡介目錄

Equipment Immunohistochemistry Market Trends and Forecast

The future of the equipment immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes. The global equipment immunohistochemistry market is expected to reach an estimated $0.62 billion by 2028 with a CAGR of 5.1% from 2023 to 2028. The major drivers for this market are rising number chronic and infectious diseases and increasing demand for microscopy-based techniques to examine components, like protein and macromolecules, in a tissue sample.

A more than 150-page report is developed to help in your business decisions.

Equipment Immunohistochemistry Market by Segment

The study includes trends and forecast for the global equipment immunohistochemistry market by application, end use, and region, as follows:

Equipment Immunohistochemistry Market by Application [Shipment Analysis by Value from 2017 to 2028]:

  • Diagnostics
  • Cancer
  • Infectious
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Research
  • Forensic
  • Others

Equipment Immunohistochemistry Market by End Use [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals
  • Diagnostic Laboratories
  • Academic Institutes
  • Others

Equipment Immunohistochemistry Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Equipment Immunohistochemistry Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies equipment immunohistochemistry companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the equipment immunohistochemistry companies profiled in this report include.

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories

Equipment Immunohistochemistry Market Insights

  • Lucintel forecasts that diagnostic segment is expected to witness the highest growth over the forecast period due to the significant usage of immunohistochemistry for diagnosis of solid tumors and cytological specimens.
  • Diagnostic laboratory is expected to remain the largest segment due to the significant use of immunohistochemistry for determining the location and distribution of particular biological components within cells.
  • North America will remain the largest region due to the growing demand for immunohistochemistry equipment in diagnostic facilities and laboratories, presence of supportive reimbursement policies, and rising number of geriatric population in the region.

Features of the Equipment Immunohistochemistry Market

  • Market Size Estimates: Equipment immunohistochemistry market size estimation in terms of value ($B)
  • Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Equipment immunohistochemistry market size by various segments, such as by application, end use, and region
  • Regional Analysis: Equipment immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different applications, end uses, and regions for the equipment immunohistochemistry market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the equipment immunohistochemistry market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the equipment immunohistochemistry market size?

Answer: The global equipment immunohistochemistry market is expected to reach an estimated $0.62 billion by 2028.

Q2. What is the growth forecast for equipment immunohistochemistry market?

Answer: The global equipment immunohistochemistry market is expected to grow with a CAGR of 5.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the equipment immunohistochemistry market?

Answer: The major drivers for this market are rising number chronic and infectious diseases and increasing demand for microscopy-based techniques to examine components, like protein and macromolecules, in a tissue sample.

Q4. What are the major segments for equipment immunohistochemistry market?

Answer: The future of the equipment immunohistochemistry market looks promising with opportunities in hospitals, diagnostic laboratories, and academic institutes.

Q5. Who are the key equipment immunohistochemistry companies?

Answer: Some of the key equipment immunohistochemistry companies are as follows:

  • Roche
  • Agilent Technologies
  • Danaher
  • PHC Holding
  • Biocare Medical
  • Merck
  • Bio-Rad Laboratories

Q6. Which equipment immunohistochemistry segment will be the largest in future?

Answer: Lucintel forecasts that diagnostic segment is expected to witness the highest growth over the forecast period due to the significant usage of immunohistochemistry for diagnosis of solid tumors and cytological specimens.

Q7. In equipment immunohistochemistry market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to the growing demand for immunohistochemistry equipment in diagnostic facilities and laboratories, presence of supportive reimbursement policies, and rising number of geriatric population in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global equipment immunohistochemistry market by application (diagnostics, cancer, infectious, nephrological diseases, autoimmune diseases, neurological diseases, research, forensic, and others), end use (hospitals, diagnostic laboratories, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Equipment Immunohistochemistry Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Equipment Immunohistochemistry Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Equipment Immunohistochemistry Market by Application
    • 3.3.1: Diagnostics
    • 3.3.2: Cancer
    • 3.3.3: Infectious
    • 3.3.4: Nephrological Diseases
    • 3.3.5: Autoimmune Diseases
    • 3.3.6: Neurological Diseases
    • 3.3.7: Research
    • 3.3.8: Forensic
    • 3.3.9: Others
  • 3.4: Global Equipment Immunohistochemistry Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Diagnostic Laboratories
    • 3.4.3: Academic Institutes
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Equipment Immunohistochemistry Market by Region
  • 4.2: North American Equipment Immunohistochemistry Market
    • 4.2.1: North American Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.2.2: North American Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.3: European Equipment Immunohistochemistry Market
    • 4.3.1: European Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.3.2: European Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.4: APAC Equipment Immunohistochemistry Market
    • 4.4.1: APAC Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.4.2: APAC Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others
  • 4.5: ROW Equipment Immunohistochemistry Market
    • 4.5.1: ROW Equipment Immunohistochemistry Market by Application: Diagnostics, Cancer, Infectious, Nephrological Diseases, Autoimmune Diseases, Neurological Diseases, Research, Forensic, and Others
    • 4.5.2: ROW Equipment Immunohistochemistry Market by End Use: Hospitals, Diagnostic Laboratories, Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Equipment Immunohistochemistry Market by Application
    • 6.1.2: Growth Opportunities for the Global Equipment Immunohistochemistry Market by End Use
    • 6.1.3: Growth Opportunities for the Global Equipment Immunohistochemistry Market by Region
  • 6.2: Emerging Trends in the Global Equipment Immunohistochemistry Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Equipment Immunohistochemistry Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Equipment Immunohistochemistry Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Roche
  • 7.2: Agilent Technologies
  • 7.3: Danaher
  • 7.4: PHC Holding
  • 7.5: Biocare Medical
  • 7.6: Merck
  • 7.7: Bio-Rad Laboratories